Atrium Therapeutics, Inc. (RNA) revenue

Revenue · fiscal 2025
$18.62M

Atrium Therapeutics, Inc. (RNA) reported revenue of $18.62M in fiscal 2025 (the year ended December 31, 2025). That is 70.9% higher than the $10.90M of fiscal 2024. Figures as of 18 Nov 2026, 04:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$18.62M
Change on fiscal 2024
+70.9%
Growth, 5 years
+22.4% a year
Highest on record
$18.62Mfiscal 2025
Lowest on record
$379.00Kfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Atrium Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 22.4% a year. Across the 8 fiscal years on record (2018–2025), the highest was $18.62M in fiscal 2025 and the lowest $379.00K in fiscal 2018.

History · 8 fiscal years

Revenue by fiscal year

Atrium Therapeutics, Inc. revenue, year by year

Atrium Therapeutics, Inc. (RNA) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$18.62M 70.9% up
2024$10.90M 11.6% up
2023$9.76M 5.9% up
2022$9.22M 1.1% down
2021$9.33M 37.4% up
2020$6.79M 192.7% up
2019$2.32M 511.9% up
2018$379.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on RNA

Atrium Therapeutics, Inc., figure by figure

Atrium Therapeutics, Inc. (RNA) overview: price, valuation and scorecard

Atrium Therapeutics, Inc. revenue: questions and answers

What is Atrium Therapeutics, Inc.'s revenue?

Atrium Therapeutics, Inc. (RNA) reported revenue of $18.62M in fiscal 2025 (the year ended December 31, 2025). That is 70.9% higher than the $10.90M of fiscal 2024.

What is the growth rate of Atrium Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 22.4% a year.

What are the highest and lowest revenue figures on record for Atrium Therapeutics, Inc.?

Across the 8 fiscal years on record (2018–2025), the highest was $18.62M in fiscal 2025 and the lowest $379.00K in fiscal 2018.

How is Atrium Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Atrium Therapeutics, Inc. (RNA) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RNA/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.